0001801885-24-000001.txt : 20240712 0001801885-24-000001.hdr.sgml : 20240712 20240712131414 ACCESSION NUMBER: 0001801885-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240712 DATE AS OF CHANGE: 20240712 EFFECTIVENESS DATE: 20240712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oisin Biotechnologies, Inc. CENTRAL INDEX KEY: 0001801885 ORGANIZATION NAME: IRS NUMBER: 465167496 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-518582 FILM NUMBER: 241113904 BUSINESS ADDRESS: STREET 1: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206-880-1166 MAIL ADDRESS: STREET 1: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0001801885 Oisin Biotechnologies, Inc. 800 5TH AVENUE, SUITE 4100 SEATTLE WA WASHINGTON 98104 206-880-1166 DELAWARE None None Corporation true Matthew Scholz c/o Oisin Biotechnologies, Inc. 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Director Gary Hudson c/o Oisin Biotechnologies, Inc. 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Director David Gobel c/o Oisin Biotechnologies, Inc. 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Director Eric Garcia c/o Oisin Biotechnologies, Inc. 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Stephen Hilbert c/o Oisin Biotechnologies, Inc. 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Danjuma Quarless c/o Oisin Biotechnologies, Inc. 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Director John Lewis c/o Oisin Biotechnologies, Inc. 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Biotechnology Decline to Disclose 06b false 2024-06-28 false true false 0 17879999 5380000 12499999 false 36 0 0 0 false Oisin Biotechnologies, Inc. /s/ Matthew Scholz Matthew Scholz President & CEO 2024-07-12